Cangene bioPharma (Formerly Known as Chesapeake Biological Laboratories, Inc. (CBL)) Announces First Quarter Financial Results For Fiscal 2010; Contract Deliveries Remain On Target And The Company Is Now Increasing Its Focus On The U.S. Commercial Market

TORONTO and WINNIPEG, Dec. 14 /CNW/ - Cangene Corporation today reports financial results for the first quarter ended October 31, 2009.

MORE ON THIS TOPIC